Storia in 3 fonti

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

Raccontata da

healio.com

statnews.com

independent.co.uk

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo3 mesi fa

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

originale

healio.com3 mesi fa

‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

CHICAGO — The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with localized high-risk prostate cancer, according to findings presented in ASCO Annual…

Leggi questa versione → originale

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Confronto fonti

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

Timeline cronologica

‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Prostate cancer breakthrough as drug combo gives patients a powerful new chance

Prostate cancer breakthrough as drug combo gives patients a powerful new chance